A skin sample taken early in life can help researchers ask what was measurable before a child was diagnosed with eczema. In Singapore, Ta and colleagues compared early skin measurements in infants who later differed in diagnosis. The timing makes this a useful study of possible early markers. The composition of the sample matters just as much when asking what a future prediction tool would tell parents.
- The nested analysis included 119 infants, 60 with atopic dermatitis diagnosed by 18 months and 59 controls.
- The published abstract lists scheduled sampling at week one and months three, six and 18.
- The case fraction was 50.4% of the analytic comparison. Estimating a baby’s future risk would require validation in a group that reflects the population where the tool would be used.
- Paper date
- 21 November 2026
- Setting
- Singapore S-PRESTO cohort
- Analytic sample
- 119 infants
- Primary endpoint
- Physician-diagnosed atopic dermatitis by 18 months
Original publication: 21 Nov 2026 · The date above refers to this brief.
Who was included in the infant skin analysis?
infants
From an early measurement to a prediction question
Set the prediction age
Use measurements available at that time.
Define the later outcome
Record diagnoses by a fixed age, here 18 months.
Test in another group
Compare predicted probabilities with observed outcomes in a new cohort.
What was measured and when
The team collected material from the surface of skin without visible lesions using tape strips. The abstract describes repeated collection at week one and at three, six and 18 months. The investigators compared patterns in molecules from the skin and its resident microbes. They report some group differences before recorded clinical signs. Measurements taken after a diagnosis answer a different question from those taken before it. A prediction model for a particular age would need to use only the information available by that age.
Source 1 ↗The fraction describes the comparison group
The original S-PRESTO study enrolled women before pregnancy and followed families into childhood. The new paper describes a nested analysis of 119 infants, with 60 cases and 59 controls. Dividing 60 by 119 gives 50.4%. That percentage describes who was in the analysis. A frequency estimate for the parent cohort would require all eligible infants, their follow-up and a record of how the comparison participants were selected. A similar distinction applies when an image study compares fixed numbers of cases and controls.
Source 1 ↗Source 2 ↗From ranking risk to estimating a probability
A candidate marker can help rank one infant above another in an analysis. A probability needs another check. Among infants given roughly the same predicted chance, the observed proportion diagnosed by 18 months should be close to that chance in an independent group. Researchers call this calibration. A paper may report how well a model separates the two outcome groups before anyone knows how well the predicted probabilities transfer to an ordinary clinic population.
Source 1 ↗Which follow-up would make the result easier to apply?
A follow-up could freeze the prediction model at a stated age and test it with newly recruited infants. Readers could then see which measurements were available before diagnosis, how many visits were missed, how well probabilities matched outcomes, and how errors varied across settings. The available abstract reports promising model performance in broad terms. This review can establish the design and sample counts from that abstract, while the numerical performance and validation remain outside its scope.
Source 1 ↗Keep the study sample separate from the risk estimate
Publisher abstract and publication record for the accepted article. Checked the analytic group counts, sample timing and endpoint. Performance metrics and validation details were outside the available source scope.
01What does 60 of 119 mean?
- What was observed
- Sixty cases and 59 controls formed the nested comparison.
- Where the conclusion stops
- The calculated 50.4% describes this analysis and requires a different sampling frame to estimate population frequency.
Source 1 · Published abstract
02What can the order of measurements show?
- What was observed
- Early skin signals were reported before clinical signs.
- Where the conclusion stops
- Timing helps motivate a prediction study. It cannot by itself identify a cause.
Source 1 · Published abstract, sampling and endpoints
Numbers you can inspect
| Measure | Value & unit | Origin & method |
|---|---|---|
| Infants in the analysis | 119 infants | Reported Nested comparison in the Singapore cohort. Source 1 · Published abstract |
| Atopic dermatitis cases | 60 infants | Reported Cases in the analysis with diagnosis by 18 months. Source 1 · Published abstract |
| Controls | 59 infants | Reported Comparison group in the analysis. Source 1 · Published abstract |
| Case fraction of the analytic sample | 50.4 percent | Calculated Divide 60 by 119 and multiply by 100, rounded to one decimal. Source 1 · Published abstract |
| Age limit for the diagnosis endpoint | 18 months of age | Reported Physician diagnosis assessed by this age. Source 1 · Published abstract |
Compare the actual experiments
These studies answer different questions. Read the unit and endpoint before comparing results.
| Study | Unit & setting | Readout | Interpretation boundary |
|---|---|---|---|
| Parent cohort and nested analysis Source 2 · Loo et al., Study design | Families enrolled before pregnancy and 119 selected infants | Prospective follow-up and a comparison of two outcome groups | An outcome fraction in the nested analysis describes its composition. |
| Early marker and later prediction check Source 1 · Published abstract, sample timing and endpoint | Infant skin samples and diagnoses in a separate group | Candidate marker timing and eventual calibration | An independent group can show whether probabilities match diagnoses outside the original analysis. |
The export includes claims, available numbers, methods and source locations. It contains our reading notes and published summaries; it is not raw participant data or an independent reanalysis.
Evidence update · 22 Nov 2026
First publication. Any calculations in this brief use reported figures. The reading notes identify possible follow-up questions. AI source check; no human editorial or clinical review.
What three study details can tell a reader
| Detail | Published abstract | Interpretation |
|---|---|---|
| Early sample | Skin measurements starting in week one | Possible lead time before a recorded diagnosis. |
| Cases and controls | 60 diagnosed infants and 59 controls | Composition of the analytic comparison. |
| Diagnosis window | Physician diagnosis by 18 months | The outcome and time horizon a model would have to predict. |
Press-News reading aid based on the primary abstract and parent cohort profile.
Your questions, answered
Did half of all babies in the cohort develop eczema?
The 50.4% figure comes from the counts in the nested comparison. To estimate frequency, use the whole eligible cohort and account for follow-up.
What condition did the researchers count?
The primary endpoint was atopic dermatitis, a form of eczema, diagnosed by a physician by the age of 18 months.
Is 50.4% a measure of model accuracy?
It is the proportion of cases in the analysed sample. The abstract does not give a numerical model performance estimate.
What is calibration in this example?
It is agreement between assigned probabilities and observed diagnosis frequencies at a stated age in the population where the model is evaluated.
Limits of this interpretation
- The publisher made an accepted article record and abstract available for this review. The abstract gives no numerical model performance estimates.
- The reported group counts describe a nested analysis. The parent cohort’s diagnosis frequency requires a separate denominator.
- A temporal lead can help identify candidate markers. A causal explanation would require other evidence.
Sources & transparency
- Ta, Wearne, Lim et al. (2026) — Early-life skin molecular signatures are predictive of atopic dermatitis risk in an Asian preconception birth cohort
Publisher abstract and publication record for the accepted article. Checked the analytic group counts, sample timing and endpoint. Performance metrics and validation details were outside the available source scope. · Accessed 22 Nov 2026
DOI: 10.1038/s41467-026-79674-4 - Loo et al. (2021) — Cohort profile of S-PRESTO
Published profile of the parent cohort. Checked enrolment before pregnancy and the design for repeated infant visits. · Accessed 22 Nov 2026
DOI: 10.1007/s10654-020-00697-2
Prepared and source-checked with AI for Press-news Team. The source notes identify the material available during preparation. The article received no human editorial or clinical review. The source list supports the reported results and the calculations shown.
Source check: AI source check — primary research and stated source limits
Clinical review: Not applicable to this educational guide
Suggest a correction